GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » 3D Medicines Inc (HKSE:01244) » Definitions » 5-Year Yield-on-Cost %

3D Medicines (HKSE:01244) 5-Year Yield-on-Cost % : 0.00 (As of Oct. 31, 2024)


View and export this data going back to 2022. Start your Free Trial

What is 3D Medicines 5-Year Yield-on-Cost %?

3D Medicines's yield on cost for the quarter that ended in Jun. 2024 was 0.00.


The historical rank and industry rank for 3D Medicines's 5-Year Yield-on-Cost % or its related term are showing as below:



HKSE:01244's 5-Year Yield-on-Cost % is not ranked *
in the Biotechnology industry.
Industry Median: 1.55
* Ranked among companies with meaningful 5-Year Yield-on-Cost % only.

Competitive Comparison of 3D Medicines's 5-Year Yield-on-Cost %

For the Biotechnology subindustry, 3D Medicines's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


3D Medicines's 5-Year Yield-on-Cost % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, 3D Medicines's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where 3D Medicines's 5-Year Yield-on-Cost % falls into.



3D Medicines 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of 3D Medicines is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5

3D Medicines  (HKSE:01244) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


3D Medicines 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of 3D Medicines's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.


3D Medicines Business Description

Traded in Other Exchanges
N/A
Address
No. 3 and No. 5, Laiyang Road, Shandong, Qingdao, CHN
3D Medicines Inc is a commercial-stage biopharmaceutical company that researches, develops, and commercialization drugs in the field of managing cancer as a chronic disease. It develops differentiated immuno-oncology drugs, helping cancer patients live with prolonged survival time and quality of life. It generates all of its revenue from China.
Executives
Gong Zhaolong 2101 Beneficial owner
Zhu Pai 2101 Beneficial owner
Dragon Prosper Holdings Limited 2101 Beneficial owner
Simcere Pharmaceutical Group Limited 2101 Beneficial owner
Gong Zhaolong 2501 Other
Immunal Medixin Us Limited 2101 Beneficial owner
Kastle Limited
Shanghai Zhenlu Enterprise Management Consulting Partnership (limited Partnership) 2101 Beneficial owner
Shenzhen Efung Holding Co., Ltd. 2201 Interest of corporation controlled by you
Shenzhen Efung Investment Management Enterprise (l.p.) 2201 Interest of corporation controlled by you
Shenzhen Efung Ruishi Investment Enterprise (limited Partnership) 2201 Interest of corporation controlled by you
Zhu Jinqiao 2103 Interests held jointly with another person

3D Medicines Headlines

No Headlines